The data was published in the journal Mol Oncol in 2018. PMID: 29603594
The data was published in the journal Mol Oncol in 2018. PMID: 29603594
Serum Amyloid A antibody [115]
GTX20687
ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetSAA1
Overview
- SupplierGeneTex
- Product NameSerum Amyloid A antibody [115]
- Delivery Days Customer9
- Antibody SpecificityReacts with natural and recombinant human Serum Amyloid A (SAA) and does not cross-react with other human cytokines or growth factors tested such as IL-1beta, IL-8, MCAF, TGF-beta and EGF.
- Application Supplier NoteFor ELISA: Use at a concentration of 0.3 microg/ml. For WB: Use at a concentration of 0.1-0.5 microg/ml. Optimal dilutions/concentrations should be determined by the researcher.
- ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID115
- Concentration0.5 mg/ml
- ConjugateUnconjugated
- FormulationLiquid
- Gene ID6288
- Target nameSAA1
- Target descriptionserum amyloid A1
- Target synonymsPIG4; SAA; SAA2; serum amyloid A protein; serum amyloid A-1 protein; TP53I4; tumor protein p53 inducible protein 4
- HostMouse
- IsotypeIgG1
- Scientific DescriptionThe serum amyloid A (SAA) family comprises a number of differentially expressed lipoproteins, acute-phase SAA1 and SAA2, the former being a major component in plasma, and constitutive SAAs (C-SAAs). Although the liver is the primary site of synthesis of both SAA types, extrhepatic production has been reported. The in-vivo concentrations increase by as much as 1000 fold during inflammation. Several studies have expressed its importance in the diagnosis and monitoring of various diseases. Pathological SAA values are often detected in association with normal CRP concentrations. SAA rises earlier and more sharply than CRP.
- ReactivityHuman
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203